Anavex Life Sciences Corp (AVXL)

[TempePhil]

Georgejj, true the fda requested more Excellence trial subjects, but even before that there were twice as many Excellence subjects needed (69) as Avatar(33). And Excellence had only 29% as many sites as Avatar.
Excellence was delaying before, not surprisingly.

The FDA has requested more Excellence subjects, now 84. So there are now 2.5 times as many subjects as Avatar. And just recently, Excellence added two more sites, but there are still only 57% as many Excellence sites as Avatar sites. With 57% of the trial sites and 2.5 times the subjects...no wonder Excellence continues delaying.

Yes, there could be covid affects also, but that would affect BOTH Avatar and Excellence.

To finish sooner...add more trial sites!

Now maybe Anavex has plans for the Avatar sites, that are not pediatric, to be converted to pediatric. I have not heard anything to that effect, but that would help.